Rapid tests market size was valued at $33,329.15 million in 2020, and is projected to reach $97,606.33 million by 2030, registering a CAGR of 11.3% from 2021 to 2030. Rapid tests provide diagnostic results spontaneously to patients. They are preferably used in preliminary screenings as well as in setting with limited resources.Rapid tests are used in diagnosis of different diseases & health conditions such as influenza, malaria, cancer, pregnancy & fertility, and others.
๐๐ข๐ฌ๐ญ ๐จ๐ ๐๐๐ฒ ๐๐ฅ๐๐ฒ๐๐ซ๐ฌ :
Akers Biosciences, Abbott Laboratories (Alere Inc.),Becton, Dickinson and Company, Bio-Rad Laboratories, Inc., Danaher Corporation
๐๐จ๐ฐ๐ง๐ฅ๐จ๐๐ ๐๐๐ฆ๐ฉ๐ฅ๐ ๐๐๐ฉ๐จ๐ซ๐ญ https://www.alliedmarketresearch.com/request-sample/4633
๐๐ผ๐๐ถ๐ฑ-๐ญ๐ต ๐ฆ๐ฐ๐ฒ๐ป๐ฎ๐ฟ๐ถ๐ผ:
The outbreak of coronavirus (COVID-19) began in late December, 2019 in Hubei province of Wuhan city in China. The virus, namely, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is transmitted among humans. The application of COVID-19 rapid test is useful in detection of corona virus, and thus provides essential guidance for subsequent diagnosis, evaluation, and treatment of COVID-19. The demand for COVID-19 rapid test increased with surge in number of COVID-19 patients.
๐๐ฎ๐ฒ ๐๐จ๐ฐ https://www.alliedmarketresearch.com/checkout-final/d63e38e386748f02acdd99fd53eeaf42
Based on application, the glucose monitoring segment occupied the largest share in 2020, and is anticipated to dominate the rapid tests market during the forecast period due to increase in prevalence of diabetes and growth in awareness of home care glucose rapid tests kits. On the other side, infectious disease segment is expected to exhibit the fastest market growth during the forecast period owing to surge in prevalence of infectious disease and surge in demand for low cost & accurate rapid tests for preliminary infectious disease testing.
Based on end user, the home care segment occupied the largest share in 2020 and is anticipated to continue its dominance during the forecast period, due to increased demand for personalized care rapid tests and cost-efficient product availability. On the other side, the hospital & clinic segment is anticipated to exhibit the fastest market growth during the forecast period due to increase in demand for rapid tests.
North America was the leading revenue contributor to the global rapid tests market in 2020, attributed to high use of rapid tests due to increase in awareness of preliminary screening and rise in incidence of chronic diseases in the region. However, Asia-Pacific is anticipated to grow at the highest CAGR of 10.5% during the study period, owing to growth in affordability, surge in healthcare expenditure, and rise in awareness toward rapid tests.
๐
๐จ๐ซ ๐๐ฎ๐ซ๐๐ก๐๐ฌ๐ ๐๐ง๐ช๐ฎ๐ข๐ซ๐ฒ https://www.alliedmarketresearch.com/purchase-enquiry/4633
๐๐๐ ๐
๐๐๐๐๐๐๐ ๐๐
๐๐๐ ๐๐๐๐๐
- Based on product, the over-the-counter (OTC) rapid test product segment is expected to show the fastest rapid tests market growth, at a CAGR of 11.9% from 2021 to 2030.
- Based on application, the glucose monitoring segment held maximum global rapid tests market share in 2020 and is expected to remain dominant throughout the forecast period.
- Based on end user, the hospitals & clinicssegment exhibited growth at a CAGR of 11.8% from 2021 to 2030.
- Based on region, Asia-Pacific is projected to experience growth at the highest rate, registering a CAGR of 12.8% during the forecast period
About Us
Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of โMarket Research Reportsโ and โBusiness Intelligence Solutions.โ AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.
Pawan Kumar, the CEO of Allied Market Research, is leading the organization toward providing high-quality data and insights. We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.
Contact:
David Correa
5933 NE Win Sivers Drive
205, Portland, OR 97220
United States
USA/Canada (Toll Free): +1-800-792-5285, +1-503-894-6022
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1(855)550-5975
help@alliedmarketresearch.com